
Recursion Pharmaceuticals (RXRX) Market Capitalization Overview
Market Cap: $2.12B as of Jul 2, 2025
$2.12B
Past Month+$341.46M (19.22%)
As of Jul 2, 2025, Recursion Pharmaceuticals (RXRX) has a market capitalization of $2.12B. Over the past 30 days, its market cap has increased by 17.39%, while in the last 12 months, it has decreased by -19.83%.
Market capitalization represents the total value of Recursion Pharmaceuticals as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Recursion Pharmaceuticals (RXRX) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Recursion Pharmaceuticals (RXRX) helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Recursion Pharmaceuticals as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Recursion Pharmaceuticals (RXRX) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Recursion Pharmaceuticals (RXRX) helps investors assess the company's size and compare it with competitors for better investment decisions.
Recursion Pharmaceuticals (RXRX) Market Cap & Key Trends
See Recursion Pharmaceuticals’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in Recursion Pharmaceuticals (RXRX)
Order type
Buy in
Order amount
Est. shares
0 shares
Recursion Pharmaceuticals (RXRX) Market Cap History
Date | Market Cap | Change |
---|---|---|
Jul 1, 2025 | $2.09B | +17.39% |
Jun 2, 2025 | $1.78B | -19.66% |
May 1, 2025 | $2.22B | +7.95% |
Apr 1, 2025 | $2.05B | -20.46% |
Mar 3, 2025 | $2.58B | -9.10% |
Feb 3, 2025 | $2.84B | +0.55% |
Jan 2, 2025 | $2.82B | -4.40% |
Recursion Pharmaceuticals (RXRX) End of Year Market Cap History
Date | Market Cap | Change |
---|---|---|
2025 | $2.12B | -19.83% |
2024 | $2.65B | +24.10% |
2023 | $2.13B | +45.65% |
2022 | $1.47B | -49.36% |
2021 | $2.89B | — |
FAQs About Recursion Pharmaceuticals (RXRX) Market Cap
As of Jul 2, 2025, the market capitalization of Recursion Pharmaceuticals (RXRX) is $2.12B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Recursion Pharmaceuticals’s market capitalization has increased by 19.22%, changing from $1.78B to $2.12B as of Jul 2, 2025.
In the last 3 months, Recursion Pharmaceuticals’s market capitalization has increased by —, changing from – to – as of –.
In the year 2024, Recursion Pharmaceuticals’s market capitalization increased from $2.13B in January to $2.65B in December, reflecting a 24.1% change.
In the past five years, Recursion Pharmaceuticals (RXRX) has had a compound annual growth rate (CAGR) of -2.19% in market capitalization. This means its market cap has shrunk at an average rate of -2.19% per year.